Shares of AstraZeneca PLC have moved -2.4% today, and are now trading at a price of $81.09. In contrast, the S&P 500 index saw a 1.0% change. Today's trading volume is 7,031,194 compared to the stock's average volume of 4,171,961.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Based in Cambridge, United Kingdom the company has 89,900 full time employees and a market cap of $251,440,742,400. AstraZeneca PLC currently offers its equity investors a dividend that yields 3.6% per year.
The company is now trading -10.78% away from its average analyst target price of $90.89 per share. The 11 analysts following the stock have set target prices ranging from $74.0 to $103.0, and on average give AstraZeneca PLC a rating of buy.
Over the last 52 weeks, AZN stock has risen 24.7%, which amounts to a 4.2% difference compared to the S&P 500. The stock's 52 week high is $87.68 whereas its 52 week low is $60.47 per share. Based on AstraZeneca PLC's average net margin growth of 6.3% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 45,811,000 | 5,961,000 | 13 | 85.71 |
| 2022 | 44,351,000 | 3,293,000 | 7 | inf |
| 2021 | 37,417,000 | 115,000 | 0 | -100.0 |
| 2020 | 26,617,000 | 3,144,000 | 12 | 140.0 |
| 2019 | 24,384,000 | 1,227,000 | 5 | -44.44 |
| 2018 | 22,090,000 | 2,050,000 | 9 |
